Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab

Overview of attention for article published in Journal of Translational Medicine, October 2012

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 49 Mendeley
citeulike: 1 CiteULike

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

INTEGRATED ANALYSIS TO DETERMINE PROGNOSIS AFTER TREATMENT FOR PRIMARY BREAST CANCER

Application EP-3387443-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.